Brokinkel Benjamin, Yavuz Murat, Warneke Nils, Brentrup Angela, Hess Katharina, Bleimüller Caroline, Wölfer Johannes, Stummer Walter
Department of Neurosurgery, University Hospital Münster, Albert-Schweitzer-Campus 1, Building A1, 48149, Münster, Germany.
Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany.
Acta Neurochir (Wien). 2017 Jul;159(7):1237-1240. doi: 10.1007/s00701-017-3120-5. Epub 2017 Feb 24.
Despite considerable advances in preoperative and intraoperative imaging and neuronavigation, resection of thalamic gliomas remains challenging. Although both endoscopic biopsy and third ventriculostomy (ETV) for the treatment of secondary hydrocephalus are commonly performed, endoscopic resection of thalamic gliomas has been very sparsely described.
We report and illustrate the surgical procedure and patient's outcome after full endoscopic resection of a thalamic glioma and to discuss this approach as an alternative to open microsurgery.
In 2016, a 56-year-old woman presented with disorientation, dysphasia and right facial hypaesthesia in our department. Cranial magnetic resonance imaging revealed a left thalamic lesion and subsequent hydrocephalus. Initially, hydrocephalus was treated by ETV but forceps biopsy was not diagnostic. However, metabolism in F-fluoroethyl-L-tyrosine positron emission tomography indicated glioma. Subsequently, endoscopic and neuronavigation-guided tumour resection was performed using a <1 cm, trans-sulcal approach through the left posterior horn of the lateral ventricle. While visibility was poor using the intraoperative microscope, neuroendoscopy provided excellent visualisation and allowed safe tumour debulking. Neither haemorrhage from the tumour or collapse of the cavity compromised endoscopic resection.
In accordance with one previously published case of endoscopic resection of a thalamic glioma, no surgery-related complications were observed. Although this remains to be determined in larger series, endoscopic resection of these lesions might be a safe and feasible alternative to biopsy or open surgery. Future studies should also aim to identify patients specifically eligible for these approaches.
尽管术前和术中成像以及神经导航技术取得了长足进展,但丘脑胶质瘤的切除仍然具有挑战性。虽然内镜活检和第三脑室造瘘术(ETV)常用于治疗继发性脑积水,但关于丘脑胶质瘤的内镜切除术的描述却非常少见。
我们报告并阐述了一例丘脑胶质瘤全内镜切除术后的手术过程及患者预后,并讨论了这种方法作为开放性显微手术替代方案的可能性。
2016年,一名56岁女性因定向障碍、言语困难和右侧面部感觉减退就诊于我院。头颅磁共振成像显示左侧丘脑有病变并伴有脑积水。最初,通过ETV治疗脑积水,但钳取活检未能明确诊断。然而,F-氟乙基-L-酪氨酸正电子发射断层扫描显示有胶质瘤代谢迹象。随后,采用小于1厘米的经沟入路,通过左侧侧脑室后角进行内镜和神经导航引导下的肿瘤切除术。术中显微镜下视野不佳,而神经内镜提供了极佳的视野,使肿瘤得以安全地大部分切除。肿瘤出血和腔隙塌陷均未影响内镜切除。
与之前发表的一例丘脑胶质瘤内镜切除术病例一致,未观察到与手术相关的并发症。尽管这一点仍有待更大规模的系列研究来确定,但这些病变的内镜切除术可能是活检或开放手术的一种安全可行的替代方案。未来的研究还应致力于确定特别适合这些方法的患者。